Back to Search
Start Over
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.
- Source :
-
Haematologica [Haematologica] 2017 Mar; Vol. 102 (3), pp. e104-e107. Date of Electronic Publication: 2016 Dec 01. - Publication Year :
- 2017
- Subjects :
- Biomarkers, Tumor blood
Bortezomib therapeutic use
Disease Progression
Gene Expression
Humans
Immunoglobulin Light Chains blood
Immunoglobulin M blood
Immunoglobulins blood
Lenalidomide
Multiple Myeloma genetics
Multiple Myeloma mortality
Multiple Myeloma therapy
Prognosis
Recurrence
Stem Cell Transplantation
Survival Analysis
Thalidomide analogs & derivatives
Thalidomide therapeutic use
Antineoplastic Agents therapeutic use
Biomarkers, Tumor genetics
Immunoglobulin Light Chains genetics
Immunoglobulin M genetics
Immunoglobulins genetics
Multiple Myeloma diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 102
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Editorial & Opinion
- Accession number :
- 27909220
- Full Text :
- https://doi.org/10.3324/haematol.2016.154070